Haematological Malignancies

• Congress Highlights 2 - Haematological malignancies
• A randomized, open-label, non-inferiority study comparing the efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with...
• Malignant lymphoma detected by screening program with esophagogastroduodenoscopy of one private screening center in Japan
• EONS Poster - Nurse led follow-up for CML patients on oral cancer treatment
• EONS Poster - Assesing the effect of telephone support on patients with myeloma Multiple (MM) in The Catalan Oncology Institut in Girona
• Multiple myeloma - Next generation diagnostics
• Multiple myeloma - Frontline treatment
• Multiple myeloma - Relapsed disease
• Molecular profile of AML and prognostication/risk classification
• FLT3-ITD mutated AML: A special entity?
• New approaches on the management of relapsed or refractory FLT3-ITD mutated AML
• Poster Discussion session - Haematological malignancies - Invited Discussant 1008PD and 1009PD
• ALK positive Anaplastic large cell lymphoma: molecular diagnosis and minimal residual disease monitoring
• Intensified 14 day rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (RCHOP14) compared to RCHOP21 in patients with newly diagno...
• Evaluation of safety, tolerability and efficacy of Temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) i...
• A comparative study of 18F-FDG PET/CT with bilateral bone marrow trephine biopsy for assessment of bone marrow infiltration by lymphoma
• Poster Discussion session - Haematological malignancies - Invited Discussant 1010PD, 1011PD, 1012PD and 1013PD
• Phase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies
• A prospective study of first-line Helicobacter pylori eradication therapy in treating localized extragastric mucosa-associated lymphoid tissue lymp...
• Bendamustine and rituximab followed by 90Y-ibritumomab tiuxetan for relapsed follicular lymphoma; a preliminary analysis of a multicenter, prospect...
• Poster Discussion session - Haematological malignancies - Invited Discussant 1014PD, 1015PD and 1016PD
• Trametinib synergizes with dexamethasone in KRAS-mutant myeloma cell lines through modulation of NDRG1 and induction of apoptosis
• Overexpression of NAMPT in adult T-cell leukemia/lymphoma patients and anti-tumor activity of a NAMPT inhibitor in vivo
• Multiple Myeloma Metal Levels and Proteasome Activity
• Phase I Study of CC-90011 in Patients With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL)

• « Previous
• 1
• 2
• ...
• 43
• Next »